SUPPLEMENTARY INFORMATION

Size: px
Start display at page:

Download "SUPPLEMENTARY INFORMATION"

Transcription

1 SUPPLEMENTARY INFORMATION doi: /nature22976 Supplementary Discussion The adaptive immune system uses a highly diverse population of T lymphocytes to selectively recognize and respond to antigenic proteins. Individual T lymphocytes generate and express single recombinants from a massive repertoire of combinatorially generated T-cell receptors (TCRs) with diversification mechanisms that could theoretically produce in excess of (~10 16 ) unique heterodimers 4. Because of this extreme diversity, individuals typically share only ~1% of their TCR seqences, and even monozygotic twins-with identical HLA haplotypes, only share ~2% 1,3,24,25. The major αβ form of the TCR heterodimer typically recognizes peptide fragments of larger proteins, bound to major histocompatibility complex (MHC) or related molecules and displayed on the cell surface 26. The unique TCR recombinantly produced by each T lymphocyte imbues it with a unique TCR specificity the ability to selectively recognize and respond to a given peptide-mhc (pmhc) complex or set of complexes. While αβ TCRs are highly specific for a given peptide-mhc ligand, such that a small change in an amino acid side chain of the peptide or TCR is sufficient to eliminate binding, it is also very common for there to be cross-reactivity to similar and even non-homologous peptides bound to the same or a different MHC. This appears to be due to a flexibility in the TCR binding site, allowing multiple stable conformations 27. Although advances in high-throughput sequencing technologies now enable the routine analysis of millions of T-cell receptors in a single experiment, there has been no systematic way to organize groups of TCR sequences according to their likely antigen specificities. Relying on tetramer-sorted TCR "training" dataset, we successfully developed a novel algorithm to search for and automatically cluster TCR sequences into distinct groups according to their likely specificity. This algorithm, Grouping Lymphocyte Interactions by Paratope Hotspots or GLIPH, combines global TCR sequence similarity, local CDR sequence similarity (motifs), spatial peptideantigen contact propensity, V-segment bias, CDR3 length bias, shared HLA alleles among TCR contributors, and clonal expansion bias, together with other observations concerning TCR specificity from the literature, to identify and cluster TCR sequences in specificity groups sets of TCRs that are likely to be recognizing the same or very similar peptide-mhc ligands (Extended Data Fig. 3, The algorithm first searches in parallel for global and local similarity signatures. For local similarity signatures, it tests for enrichment of any 2, 3, and 4 1

2 RESEARCH SUPPLEMENTARY INFORMATION amino acid continuous motifs within CDR3 β sequences while excluding conserved N-terminal V region or C-terminal J region CDR3 amino acid positions (IMGT 104, 105, 106, 117, and 118) that have never been observed to bind the antigenic peptide in crystal structures (Extended Data Fig. 1). Optionally it can also search for discontinuous amino acid motifs in CDR3 that allow any amino acid at a position, with specific 2, 3, or 4 amino acids around that position. A motif is considered enriched if it is elevated at least 10-fold over expected frequency in the naïve TCR reference pool, with a probability<0.001 being at that level of enrichment by chance. In parallel, it also identifies global similarity sequences with CDR3 β sequences that are identical or only differ by one amino acid and are of the same length. Next, it clusters these TCRs with identified similarities, gathering together variants of similar amino acid motifs or global CDR3 similarity into a single sequence group in the process. Finally, GLIPH confirms the significance of the formed clusters through evaluation of enrichment of independent features, including V-gene usage, CDR3 length distribution, clonal expansion bias and donor HLA usage in each sequence group. This three-step process of motif nucleation creates a powerful statistical framework for identifying TCRs that recognize the same antigen. Optionally, GLIPH can restrict cluster members to only those TCRs that share the same V- gene. When HLA genotypes for the donors are available, GLIPH also provides a predicted HLArestriction for each TCR sequence group generated. This HLA allele prediction can then in turn be used to score databases of candidate peptides, ranking them according to their odds of being the target antigen. While previous studies have noted that certain TCR positions are more likely to be in contact with antigen, or that distributions of short TCR CDR3β motifs systematically alter after immunization 5,28, no other TCR repertoire analysis tools that we are aware of are able to formalize these observations into a unified framework for automated TCR sequence group identification, with statistical validation and HLA prediction GLIPH can cluster TCR sequences based on their likely antigen specificity, predict their likely HLA restriction and prioritize specific peptide antigen candidates. Our data also indicates that linear, usually continuous motifs of 3-4 amino acids in CDR3β and CDR3α, are often highly conserved in TCRs that recognize the same peptide-mhc ligand, and that in known structures, these are the residues responsible for contacting the antigenic peptide. This builds and expands on previous work by Chain and colleagues indicating that 3 amino acid motifs in the TCR CDR3 regions are often correlated with antigen specific responses 28. While GLIPH requires the HLA genotypes of the subjects in order to make an HLA prediction, in our Mtb dataset of 22 individuals there were 69 unique class II HLAs, and in each evaluated sequence group we were able to predict the presenting HLA. Similarly 2

3 SUPPLEMENTARY INFORMATION RESEARCH while GLIPH cannot predict a specific target peptide a-priori, knowing the HLA and a candidate population of peptides, it is possible to prioritize the peptides by predicted binding to the candidate HLA, greatly reducing the combinations of APCs and peptides to be tested. Where no pool of candidate antigens is available, the HLA-prediction facilitates the use of the pmhc yeast display libraries developed by Garcia and colleagues 27. An important question is - how much of the TCR repertoire will GLIPH capture? Here the limited data we have at this time is that it will be substantial, in that of the >2000 TCR sequences that we analyzed in Fig 3A, up to 14% could be gathered into high-confidence discrete specificity groups with GLIPH, with rarefaction suggesting that more groups could be identified if more data was available. Similarly (14%; 796/5711) of the TCRs fit into specificity groups in the Mtb cohort. A partial solution to this problem will likely come from larger sample sizes, although in very diverse populations, such as the South African cohort analyzed here, there will HLA alleles that will be very rare and those only in very large population studies will there be enough matches that could generate shared TCR specificities. Nonetheless, building large TCR data bases around specific diseases, or TCR-omes, could be very valuable in assessing the responses of individuals or cohorts, even if only a fraction of the TCR sequences can be clustered using GLIPH. 24 Naylor, K. et al. The influence of age on T cell generation and TCR diversity. Journal of immunology 174, (2005). 25 Robins, H. S. et al. Comprehensive assessment of T-cell receptor beta-chain diversity in alphabeta T cells. Blood 114, , doi: /blood (2009). 26 Garcia, K. C. et al. An alphabeta T cell receptor structure at 2.5 A and its orientation in the TCR- MHC complex. Science 274, (1996). 27 Birnbaum, M. E. et al. Deconstructing the peptide-mhc specificity of T cell recognition. Cell 157, , doi: /j.cell (2014). 28 Thomas, N. et al. Tracking global changes induced in the CD4 T-cell receptor repertoire by immunization with a complex antigen using short stretches of CDR3 protein sequence. Bioinformatics 30, , doi: /bioinformatics/btu523 (2014). 29 Bolotin, D. A. et al. MiTCR: software for T-cell receptor sequencing data analysis. Nature methods 10, , doi: /nmeth.2555 (2013). 30 Nazarov, V. I. et al. tcr: an R package for T cell receptor repertoire advanced data analysis. BMC bioinformatics 16, 175, doi: /s (2015). 31 Yu, Y., Ceredig, R. & Seoighe, C. LymAnalyzer: a tool for comprehensive analysis of next generation sequencing data of T cell receptors and immunoglobulins. Nucleic acids research 44, e31, doi: /nar/gkv1016 (2016). 3

4 RESEARCH SUPPLEMENTARY INFORMATION Supplementary Methods GLIPH Documentation ================================================================ GROUPING OF LYMPHOCYTE INTERACTIONS BY PARATOPE HOTSPOTS - GLIPH ================================================================ Questions? Comments? Contact jakeg@stanford.edu huang7@stanford.edu Name ---- gliph - Grouping of Lymphocyte Interactions by Paratope Hotspots Synopsis gliph [options ] --tcr TCR_TABLE --hla HLA_TABLE Description GLIPH clusters TCRs that are predicted to bind the same MHC-restricted peptide antigen. When multiple donors have contributed to the clusters, and HLA genotypes for those donors are available, GLIPH additionally can provide predictions of which HLA-allele is presenting the antigen. Typically the user will pass in a sequence set of hundreds to thousands of TCR sequences. This dataset will be analyzed for very similar TCRs, or TCRs that share CDR3 motifs that appear enriched in this set relative to their expected frequencies in an unselected naive reference TCR set. GLIPH returns significant motif lists, significant TCR convergence groups, and for each group, a collection of scores for that group indicating enrichment for motif, V-gene, CDR3 length, shared HLA among contributors, and proliferation count. When HLA data is available, it predicts the likely HLA that the set of TCRs recognizes. Options Required Data Inputs ~~~~~~~~~~~~~~~~~~~~ The user must provide a table of TCR sequences. --tcr TCR_TABLE The format of the table is tab delimited, expecting the following columns in this order. Only TCRb is required for the primary component of the algorithm to function, but patient identity is required for HLA prediction. Example: 4

5 SUPPLEMENTARY INFORMATION RESEARCH CDR3b TRBV TRBJ CDR3a TRAV TRAJ Patient Counts CAADTSSGANVLTF TRBV30 TRBJ2-6 CALSDEDTGRRALTF TRAV19 TRAJ5 09/ CAATGGDRAYEQYF TRBV2 TRBJ2-7 CAASSGANSKLTF TRAV13-1 TRAJ56 03/ CAATQQGETQYF TRBV2 TRBJ2-5 CAASYGGSARQLTF TRAV13-1 TRAJ22 02/ CACVSNTEAFF TRBV28 TRBJ1-1 CAGDLNGAGSYQLTF TRAV25 TRAJ28 PBMC863 1 CAGGKGNSPLHF TRBV2 TRBJ1-6 CVVLRGGSQGNLIF TRAV12-1 TRAJ42 02/ CAGQILAGSDTQYF TRBV6-4 TRBJ2-3 CATASGNTPLVF TRAV17 TRAJ29 09/ CAGRTGVSTDTQYF TRBV5-1 TRBJ2-3 CAVTPGGGADGLTF TRAV41 TRAJ45 02/ CAGYTGRANYGYTF TRBV2 TRBJ1-2 CVVNGGFGNVLHC TRAV12-1 TRAJ35 01/ Optional Data Inputs ~~~~~~~~~~~~~~~~~~~~ The user may additional supply a table of HLA genotyping for each subject. --hla HLA_TABLE The format of the table is tab delimited, with each row beginning with the identity of a subject, and then two or more following column providing HLA identification. The number of total columns (HLA defined genotypes) is flexible. Example: 09/0217 DPA1*01:03 DPA1*02:02 DPB1*04:01 DPB1*14:01 DQA1*01:02 09/0125 DPA1*02:02 DPA1*02:02 DPB1*05:01 DPB1*05:01 DQA1*06:01 03/0345 DPA1*02:01 DPA1*02:01 DPB1*17:01 DPB1*01:01 DQA1*01:03 03/0492 DPA1*01:03 DPA1*02:01 DPB1*03:01 DPB1*11:01 DQA1*01:02 02/0259 DPA1*01:03 DPA1*01:03 DPB1*104:01 DPB1*02:01 DQA1*02:01 Optional Arguments ~~~~~~~~~~~~~~~~~~~ --refdb DB --gccutoff=1 optional alternative reference database global covergence distance cutoff. This is the maximum CDR3 Hamming mutation distance between two clones sharing the same V, same J, and same CDR3 length in order for them to be considered to be likely binding the same antigen. This number will change depending on sample depth, as with more reads, the odds of finding a similar sequence increases even in a naive repertoire. This number will also change depending on the species evaluated and even the choice of reference database (memory TCRs will be more likely to have similar TCRs than naive TCR repertoires). Thus, by default this is calculated at runtime if not specified. --simdepth=1000 simulated resampling depth for non-parametric convergence significance tests. This defines the number of random 5

6 RESEARCH SUPPLEMENTARY INFORMATION repeat samplings into the reference distribution that GLIPH performs when analyzing 1) global similarity cutoff 2) local similarity motif enrichment 3) V-gene enrichment 4) CDR3 length enrichment 5) clonal proliferation enrichment A higher number will take longer to run but will produce more reproducible results. --lcminp=0.01 local convergence minimum probability score cutoff. The score reports the probability that a random sample of the same size as the sample set would but into the reference set (i.e. naive repertoire) would generate an enrichment of the given motif at least as high as has been observed in the sample set. It is set to 0.01 by default. --lcminove=10 local convergence minimum observed vs expected fold change. This is a cutoff for the minimum fold enrichment over a reference distribution that a given motif should have in the sample set in order to be considered for further evaluation. It is set to 10 by default. --kmer_mindepth=3 minimum observations of kmer for it to be evaluated. This is the minimum number of times a kmer should be observed in the sample set in order for it to be considered for further evaluation. The number can be set higher to provide less motif-based clusters with higher confidence. This could be recommended if the sample set is greater than 5000 reads. Lowering the value to 2 will identify more groups but likely at a cost of an increase False Discovery Rate. --global=1 Search for global TCR similarity (Default 1) --local=1 Search for local TCR similarity (Default 1) --make_depth_fig=0 Perform repeat random samplings at the sample set depth in order to visualize convergence --discontinuous=0 Allow discontinuous motifs (Default 0) --positional_motifs=0 Restrict motif clustering to a shared position that is fixed from the N-terminal end of CDR3 --cdr3len_stratify=0 Stratify by shared cdr3length distribution (Default 0) --vgene_stratify=0 Stratify by shared V-gene frequency distribution (Default 0) --public_tcrs=0 Reward motifs in public TCRs (Default 0) Controlling Output ~~~~~~~~~~~~~~~~~~ GLIPH produces multiple output files. 6

7 SUPPLEMENTARY INFORMATION RESEARCH --output FILE --verbose Place command output into the named file. Have *tmo* print messages describing Definitions ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ Convergence group - a set of multiple TCRs from one or more individuals that bind the same antigen in a similar manner through similar TCR contacts. GLIPH predicts convergence groups by asking "what is the probability that this cluster of similar TCRs could have appeared without the selection of common antigen?" Global convergence - A pair of TCRs that share the same length CDR3 and differ by less than a certain number of amino acids in those CDR3s. Example: in a set of 300 random TCRs, finding two TCRs that only differ by one amino acid in their CDR3 would be highly unlikely. Local convergence - A pair of TCRs that share in their CDR3 regions an amino acid motif that appears enriched in their sample set. Optionally this common motif could be positionally constrained. Example: in the malaria set, an enriched QRW motif was found in 23 unique TCRs from 12 individuals in a conserved position in their CDR3. Reference set - A large database of TCR sequences that are not expected to be enriched for the specificities found in the sample set. Example: by default, GLIPH uses as a reference database over 200,000 nonredundant naive CD4 and CD8 TCRb sequences from 12 healthy controls. Sample set - The input collection of TCRs under evaluation that are potentially enriched for a specificity not present in the reference set. Function of Algorithm ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ GLIPH first makes the input sample set non-redundant at the CDR3 amino acid level. The identity of the V-genes, the J-genes, the clonal frequencies, and the associated HLA information for each TCR is hidden during the CDR3 analysis in order to act as independent confirmation variables of the resulting clusters. GLIPH next counts the number of unique CDR3 sequences in the sample dataset. GLIPH next calculates the minimum hamming distance from each CDR3 in the sample dataset to the next closest same-length sequence in the sample set. This result is the minimum distance distribution. GLIPH next loads the reference dataset. 7

8 RESEARCH SUPPLEMENTARY INFORMATION GLIPH next repeatedly resamples from the reference database at the nonredundant sample set depth, calculating the minimum hamming distance distribution in each case. This is repeated simdepth times (1000 by default). Probability of encountering next closest members at distant 0, 1, 2... is tabulated across all random samples. GLIPH next compares the sample set minimum hamming distance distribution to that of the reference set, to assign a probability to each hamming distance that sequences of that distance are likely to appear randomly. Example: after analysis, it is found that out of 1000 simulations hamming distance in-test-set in-ref-set probability / / GLIPH then selects a maximum hamming distance cutoff for grouping similar TCRs. NOTE: For the standard reference set this analysis has been precomputed for a range of sampling depths, enabling a lookup table rather than simulation as a runtime accelerator. GLIPH then analyzes all possible 3mer, 4mer, 5mer and discontinuous 3mer and 4mer motifs for their frequency in the sample set. This is done excluding the first three and last three residues in the CDR, as they are not observed to be in contact with antigen in known crystal structures. This is done for every non-redundant CDR3 in the reference set. Example: for a scan of the following CDR3, the following 3mers would be collected CAS SFGSGGHYE TYF xxx SFGSGGHYE xxx SFG FGS GSG SGG GGH GHY HYE SFGS FGSG GSGG SGGH GGHY GHYE S.GS F.SG (etc) The frequences off all motifs across the sample set are calculated. In order to establish whether these motifs are just naturally abundant or specifically enriched by antigen, these frequencies are compared to a repeat random sampling of the reference set at the same depth as the non-redundant database. The frequency 8

9 SUPPLEMENTARY INFORMATION RESEARCH of every motif is collected with each random sampling in order to create a distribution. If each motif could only be observed in a given sequence once, then the distribution of sampling motif frequency means u become normally distributed and this result is equivalent to calculating the frequencies of all motifs in the reference database, and then calculating one-sided confidence intervals for expected frequencies of any given motif in the reference database at any given sampling depth: _ CI(99.9% os) = y + t (s / sqrt(n)) _ where n is the sample set non-redundant CDR3 sample size, y is the motif mean frequency, and s is the SD estimate at that sampling depth for the motif, as _ 2 s = \ (y1 - y) / \ (n - 1) This approximation provides a runtime acceleration. GLIPH then compares the probability that each motif in the sample set would have appeared at the observed frequency by random change (calculated as the number of times the motif was found at at least that depth in a random sampling, divided by the total number of random samplings, or alternatively though the CI). GLIPH next generates a network of all CDR3s as nodes, and all edges as either global or local interactions. The clusters can be optionally filtered with the following arguements --positional_motifs=0 Restrict motif edges to CDR3s where the motif is in a shared position that is fixed from the N-terminal end of CDR3 --public_tcrs=0 Allow CDR3s from multiple subjects to increase the size of their clusters. Rewards public TCRs but risks contamination clouding results. --global_vgene=0 Restricts global relationships to TCRs of common V-gene Recommended but invalidates V-gene probability score GLIPH then scores each individual cluster (candidate convergence group) by evaluating a set of features that are independet of the CDR3 observations, assigning a probability p to each feature, and then combining those probabilities into a single score by conflation. For tests i through N, testing Pi(X=C) probability that cluster X is convergent, the combined conflation score is given as N P(X=C) = P (X=C) i i N N P (X=C) + P (X!=C) 9

10 RESEARCH SUPPLEMENTARY INFORMATION i i i i The individual Pi(X=C) tests include 1) global similarity probability 2) local motif probability 3) network size 4) enrichment of V-gene within cluster 5) enrichment of CDR3 length (spectratype) within cluster 6) enrichment of clonal expansion within cluster 7) enrichment of common HLA among donor TCR contributors in cluster Individual score components are calculated as follows: == 3) Calculating network size p == For each discrete cluster, the probability p of a given cluster topology can be obtained from the number of members of the cluster by comparison to a lookup table calculated from repeat random sampling and GLIPH clustering of naive TCR sequences at a range of different sampling depths n from 25 to 5000, each performed 1000 times each. Example: at sampling depth n=500, clusters of size 5 have a probabilty p=0.002 of occuring in naive TCR sample sets. == 4) enrichment of V-gene within cluster == GLIPH hides V-gene usage for all clones prior to CDR3 analysis, and does not explore the V-gene template endcoded amino acids in the local (motif) search. To evaluate whether there is an enrichment of common V-segment within the cluster over the degree that would be expected from an unbiased sampling of TCRs of cluster size n from the total dataset, we perform repeat random sampling at sample size n from the total dataset, each time obtaining the V-genes for each clone and calculating a V-gene Simpson's Diversity Index D for each sample, where D is interpreted as the probability that any two members within the cluster would share a V-gene and is calculated as V \ v(v-1) / 1 D = V \ n(n-1) / 1 where V is the number of all V-genes, v is the total counts of a given v-gene, and n is the sampling size (cluster size). The probability of the observed D for candidate convergence group is obtained as the one-tailed probability of observing a score at least that high in the D score distribution from random sampled clusters of same size n. == 4) enrichment of CDR3 within cluster == 10

11 SUPPLEMENTARY INFORMATION RESEARCH For local (motif) scoring, no stratification based on CDR3 length is performed. To evaluate whether there is an enrichment of common CDR3 length within the cluster over the degree that would be expected from an unbiased sampling of TCRs of cluster size n from the total dataset, we perform repeat random sampling at sample size n from the total dataset, each time obtaining the CDR3 lengths for each clone and calculating a V-gene Simpson's Diversity Index D for each sample, where D is interpreted as the probability that any two members within the cluster would share a CDR3length and is calculated as C \ c(c-1) / 1 D = C \ n(n-1) / 1 where C is the number of all CDR3 lengths, c is the total counts of a given CDR3 length, and n is the sampling size (cluster size). The probability of the observed D for candidate convergence group is obtained as the one-tailed probability of observing a score at least that high in the D score distribution from random sampled clusters of same size n. == 5) enrichment of clonal expansion within cluster == The first step in GLIPH is to make all CDR3s non-redundant, hiding their clone frequences. To evaluate whether there is an enrichment of expanded clones within a given convergence group, the number of counts for each clone are recovered, and a convergence group expansion coefficient e is calculated as e = total clones / total unique clones To evaluate whether there is an enrichment of expanded clones within the cluster over the degree that would be expected from an unbiased sampling of TCRs of cluster size n from the total dataset, we perform repeat random sampling at sample size n from the total dataset, each time obtaining the clone counts for each clone and calculating e for each random sample to establish a distribution. The probability of the observed e for candidate convergence group is obtained as the one-tailed probability of observing a score at least that high in the e score distribution from random sampled clusters of same size n. == 6) enrichment of common HLA among donor TCR contributors in cluster == TCRs that recognize a common antigen should be constrained by the same HLA. Thus, their contributing donors should contain that HLA allele in their genotype. When HLA genotype information is available, GLIPH uses combinatorial resampling without replacement to estimate the probability that the collection of TCRs in the convergent group recognizes any given HLA. For each HLA allele that appears at least twice in the candidate convergence group, GLIPH obtains 11

12 RESEARCH SUPPLEMENTARY INFORMATION a the number of subjects in the convergence group that harbor that allele A the number of subjects in the study that harbor that allele n the number of subjects in the convergence group N the number of subjects in the study GLIPH uses this information to calculate the probability that a given HLA allele is present by chance. Examples gliph --tcr TCR_TABLE --hla HLA_TABLE 12

13 SUPPLEMENTARY INFORMATION RESEARCH Supplementary Methods Training set curation The training set was derived from single-tcr sequencing of tet+ cells, bulk sequencing of tet+ cell pools, sequences from literature, and sequences from solved crystal structures. To simplify analysis, TCRs in the training set were curated to ensure that they were A) Real: (i.e. not a read error variant) B) Non-redundant: each sequence was only counted once per subject source C) Non-promiscuous: each TCR only associated with a single specificity A) Real (i.e. not a read error variant) Single-cell TCR sequences were sequenced to a depth of at least 1000x to eliminate read error. Bulk-cell TCR sequencing was performed in replicate. To avoid PCR error and read error, only reads identified across both replicates were retained. Frequencies of all TCRb clones were evaluated in each replicate, and any reads differing by only 1bp from a higher frequency clone were absorbed into that clone, assuming it to most likely represent a read error variant of the more dominant clone, given the read depths utilized in each replicate. Final sequences were reviewed to contain in-frame VDJ recombination and function CDR3 boundary residues. B) Non-redundant: each sequence was only counted once per subject source To avoid over-counting motifs in high-frequency clones, the data was rendered clonally non-redundant. Irrespective of how many times a clone was observed in single-cells or across reads in bulk TCR sequencing, the clones were rendered non-redundant within a given specificity and given subject. For bulk sequencing, subjects with very large numbers of singleton clones were down-sampled to use only the highest-frequency clones in comparable numbers to those presented by other subjects. This was done out of the assumption that these large populations of low-frequency singleton reads likely represented tetramer staining background from the FACS sorting, or barcode background during sequencing. It was also done ensure that each subject contributed a comparable amount of information to analysis of statistical trends in the antigen-specific repertoire. C) Non-promiscuous: each TCR only associated with a single specificity In almost all cases, a single TCR was only observed against a single specificity from a single individual. However, in the bulk TCR sequencing, there were some cases of a TCR being found across multiple specificities. In 37 of these cases, the TCR was found at high frequency in a single sample, but appeared at very low copy in some other samples. As these samples were all sequenced together, it was assumed that a low rate of DNA barcode contamination was causing a low rate of DNA sequencing read misassignment, a known issue for Illumina sequencing with multiplex identifier barcodes. To address this, sequences with clearly dominant specificities were curated to remove the presence of that clone in the presumed contaminant sources. In total 37 clones were curated in this way; three example cases are shown below. 13

14 RESEARCH SUPPLEMENTARY INFORMATION Subject HLA Antigen Counts CDRb3 Selection subject-0958 HLA-A1 CMV 3 CSVVAGGADTQYF subject-0898 HLA-A2 CMV CSVVAGGADTQYF X subject-1521 HLA-B7 CMV 4 CSVVAGGADTQYF subject-2387 HLA-A2 flu CSAISGSGGVGDTQYF X subject-2385 HLA-B7 CMV 2 CSAISGSGGVGDTQYF subject-2351 HLA-B7 flu 3 CSAISGSGGVGDTQYF subject-3183 HLA-A1 CMV 2 CASSPGTDTQYF subject-1mc1 HLA-A2 EBV 3 CASSPGTDTQYF subject-0959 HLA-B7 flu 54 CASSPGTDTQYF X There remained 49 additional clones that were found across two samples at frequencies that made unambiguous assignment challenging. Almost every cases was found between two samples: subject- 0958_HLA-A1-CMV and subject-0988_hla-b7-flu. All ambiguous clones were removed from the final curated dataset. The final dataset contained 2067 T-cell receptors of known, unique specificity, of which 47 were found across more than one source. 14

New technologies for studying human immunity. Lisa Wagar Postdoctoral fellow, Mark Davis lab Stanford University School of Medicine

New technologies for studying human immunity. Lisa Wagar Postdoctoral fellow, Mark Davis lab Stanford University School of Medicine New technologies for studying human immunity Lisa Wagar Postdoctoral fellow, Mark Davis lab Stanford University School of Medicine New strategies: Human immunology is ideal for a systems approach We have

More information

Supplementary Figure 1. Using DNA barcode-labeled MHC multimers to generate TCR fingerprints

Supplementary Figure 1. Using DNA barcode-labeled MHC multimers to generate TCR fingerprints Supplementary Figure 1 Using DNA barcode-labeled MHC multimers to generate TCR fingerprints (a) Schematic overview of the workflow behind a TCR fingerprint. Each peptide position of the original peptide

More information

Antigen Recognition by T cells

Antigen Recognition by T cells Antigen Recognition by T cells TCR only recognize foreign Ags displayed on cell surface These Ags can derive from pathogens, which replicate within cells or from pathogens or their products that cells

More information

Evidence for antigen-driven TCRβ chain convergence in the tumor infiltrating T cell repertoire

Evidence for antigen-driven TCRβ chain convergence in the tumor infiltrating T cell repertoire Evidence for antigen-driven TCRβ chain convergence in the tumor infiltrating T cell repertoire Geoffrey M. Lowman, PhD Senior Staff Scientist EACR - 02 July 2018 For Research Use Only. Not for use in diagnostic

More information

Nature Biotechnology: doi: /nbt Supplementary Figure 1. Binding capacity of DNA-barcoded MHC multimers and recovery of antigen specificity

Nature Biotechnology: doi: /nbt Supplementary Figure 1. Binding capacity of DNA-barcoded MHC multimers and recovery of antigen specificity Supplementary Figure 1 Binding capacity of DNA-barcoded MHC multimers and recovery of antigen specificity (a, b) Fluorescent-based determination of the binding capacity of DNA-barcoded MHC multimers (+barcode)

More information

Current practice, needs and future directions in immuno-oncology research testing

Current practice, needs and future directions in immuno-oncology research testing Current practice, needs and future directions in immuno-oncology research testing Jose Carlos Machado IPATIMUP - Porto, Portugal ESMO 2017- THERMO FISHER SCIENTIFIC SYMPOSIUM Immune Therapies are Revolutionizing

More information

and Jamie Rossjohn 1,2,4 *

and Jamie Rossjohn 1,2,4 * Understanding the drivers of MHC restriction of T cell receptors Nicole L. La Gruta 1,2 *, Stephanie Gras 1,2, Stephen R. Daley 1, Paul G. Thomas 3 and Jamie Rossjohn 1,2,4 * Abstract T cell discrimination

More information

Antigen Receptor Structures October 14, Ram Savan

Antigen Receptor Structures October 14, Ram Savan Antigen Receptor Structures October 14, 2016 Ram Savan savanram@uw.edu 441 Lecture #8 Slide 1 of 28 Three lectures on antigen receptors Part 1 (Today): Structural features of the BCR and TCR Janeway Chapter

More information

Use of BONSAI decision trees for the identification of potential MHC Class I peptide epitope motifs.

Use of BONSAI decision trees for the identification of potential MHC Class I peptide epitope motifs. Use of BONSAI decision trees for the identification of potential MHC Class I peptide epitope motifs. C.J. SAVOIE, N. KAMIKAWAJI, T. SASAZUKI Dept. of Genetics, Medical Institute of Bioregulation, Kyushu

More information

Nature Immunology: doi: /ni Supplementary Figure 1

Nature Immunology: doi: /ni Supplementary Figure 1 Supplementary Figure 1 A β-strand positions consistently places the residues at CDR3β P6 and P7 within human and mouse TCR-peptide-MHC interfaces. (a) E8 TCR containing V β 13*06 carrying with an 11mer

More information

Lecture 6. Burr BIO 4353/6345 HIV/AIDS. Tetramer staining of T cells (CTL s) Andrew McMichael seminar: Background

Lecture 6. Burr BIO 4353/6345 HIV/AIDS. Tetramer staining of T cells (CTL s) Andrew McMichael seminar: Background Lecture 6 Burr BIO 4353/6345 HIV/AIDS Andrew McMichael seminar: Background Tetramer staining of T cells (CTL s) 1. Vβ 19: There are 52 T cell receptor (TCR) Vβ gene segments in germ line DNA (See following

More information

Potential cross reactions between HIV 1 specific T cells and the microbiome. Andrew McMichael Suzanne Campion

Potential cross reactions between HIV 1 specific T cells and the microbiome. Andrew McMichael Suzanne Campion Potential cross reactions between HIV 1 specific T cells and the microbiome Andrew McMichael Suzanne Campion Role of the Microbiome? T cell (and B cell) immune responses to HIV and Vaccines are influenced

More information

A HLA-DRB supertype chart with potential overlapping peptide binding function

A HLA-DRB supertype chart with potential overlapping peptide binding function A HLA-DRB supertype chart with potential overlapping peptide binding function Arumugam Mohanapriya 1,2, Satish Nandagond 1, Paul Shapshak 3, Uma Kangueane 1, Pandjassarame Kangueane 1, 2 * 1 Biomedical

More information

Immunology - Lecture 2 Adaptive Immune System 1

Immunology - Lecture 2 Adaptive Immune System 1 Immunology - Lecture 2 Adaptive Immune System 1 Book chapters: Molecules of the Adaptive Immunity 6 Adaptive Cells and Organs 7 Generation of Immune Diversity Lymphocyte Antigen Receptors - 8 CD markers

More information

Significance of the MHC

Significance of the MHC CHAPTER 7 Major Histocompatibility Complex (MHC) What is is MHC? HLA H-2 Minor histocompatibility antigens Peter Gorer & George Sneell (1940) Significance of the MHC role in immune response role in organ

More information

HLA and antigen presentation. Department of Immunology Charles University, 2nd Medical School University Hospital Motol

HLA and antigen presentation. Department of Immunology Charles University, 2nd Medical School University Hospital Motol HLA and antigen presentation Department of Immunology Charles University, 2nd Medical School University Hospital Motol MHC in adaptive immunity Characteristics Specificity Innate For structures shared

More information

An innovative multi-dimensional NGS approach to understanding the tumor microenvironment and evolution

An innovative multi-dimensional NGS approach to understanding the tumor microenvironment and evolution An innovative multi-dimensional NGS approach to understanding the tumor microenvironment and evolution James H. Godsey, Ph.D. Vice President, Research & Development Clinical Sequencing Division (CSD) Life

More information

Antigen Presentation to T lymphocytes

Antigen Presentation to T lymphocytes Antigen Presentation to T lymphocytes Immunology 441 Lectures 6 & 7 Chapter 6 October 10 & 12, 2016 Jessica Hamerman jhamerman@benaroyaresearch.org Office hours by arrangement Antigen processing: How are

More information

HLA and antigen presentation. Department of Immunology Charles University, 2nd Medical School University Hospital Motol

HLA and antigen presentation. Department of Immunology Charles University, 2nd Medical School University Hospital Motol HLA and antigen presentation Department of Immunology Charles University, 2nd Medical School University Hospital Motol MHC in adaptive immunity Characteristics Specificity Innate For structures shared

More information

Transcript-indexed ATAC-seq for immune profiling

Transcript-indexed ATAC-seq for immune profiling Transcript-indexed ATAC-seq for immune profiling Technical Journal Club 22 nd of May 2018 Christina Müller Nature Methods, Vol.10 No.12, 2013 Nature Biotechnology, Vol.32 No.7, 2014 Nature Medicine, Vol.24,

More information

Supplementary Table 1. Data collection and refinement statistics (molecular replacement).

Supplementary Table 1. Data collection and refinement statistics (molecular replacement). Supplementary Table 1. Data collection and refinement statistics (molecular replacement). Data set statistics HLA A*0201- ALWGPDPAAA PPI TCR PPI TCR/A2- ALWGPDPAAA PPI TCR/A2- ALWGPDPAAA Space Group P2

More information

Completing the CIBMTR Confirmation of HLA Typing Form (Form 2005)

Completing the CIBMTR Confirmation of HLA Typing Form (Form 2005) Completing the CIBMTR Confirmation of HLA Typing Form (Form 2005) Stephen Spellman Research Manager NMDP Scientific Services Maria Brown Scientific Services Specialist Data Management Conference 2007 1

More information

The Immune Epitope Database Analysis Resource: MHC class I peptide binding predictions. Edita Karosiene, Ph.D.

The Immune Epitope Database Analysis Resource: MHC class I peptide binding predictions. Edita Karosiene, Ph.D. The Immune Epitope Database Analysis Resource: MHC class I peptide binding predictions Edita Karosiene, Ph.D. edita@liai.org IEDB Workshop October 29, 2015 Outline Introduction MHC-I peptide binding prediction

More information

Principles of Adaptive Immunity

Principles of Adaptive Immunity Principles of Adaptive Immunity Chapter 3 Parham Hans de Haard 17 th of May 2010 Agenda Recognition molecules of adaptive immune system Features adaptive immune system Immunoglobulins and T-cell receptors

More information

Major Histocompatibility Complex (MHC) and T Cell Receptors

Major Histocompatibility Complex (MHC) and T Cell Receptors Major Histocompatibility Complex (MHC) and T Cell Receptors Historical Background Genes in the MHC were first identified as being important genes in rejection of transplanted tissues Genes within the MHC

More information

Antigen capture and presentation to T lymphocytes

Antigen capture and presentation to T lymphocytes Antigen capture and presentation to T lymphocytes What T lymphocytes see Innate Immunity Immediately available or Very broad specificity rapidly recruited Adaptive Immunity Rare and naïve cells require

More information

Introduction to Immunology Part 2 September 30, Dan Stetson

Introduction to Immunology Part 2 September 30, Dan Stetson Introduction to Immunology Part 2 September 30, 2016 Dan Stetson stetson@uw.edu 441 Lecture #2 Slide 1 of 26 CLASS ANNOUNCEMENT PLEASE NO TREE NUTS IN CLASS!!! (Peanuts, walnuts, almonds, cashews, etc)

More information

Evaluation of MIA FORA NGS HLA test and software. Lisa Creary, PhD Department of Pathology Stanford Blood Center Research & Development Group

Evaluation of MIA FORA NGS HLA test and software. Lisa Creary, PhD Department of Pathology Stanford Blood Center Research & Development Group Evaluation of MIA FORA NGS HLA test and software Lisa Creary, PhD Department of Pathology Stanford Blood Center Research & Development Group Disclosure Alpha and Beta Studies Sirona Genomics Reagents,

More information

SUPPLEMENTARY INFORMATION

SUPPLEMENTARY INFORMATION Supplementary Notes 1: accuracy of prediction algorithms for peptide binding affinities to HLA and Mamu alleles For each HLA and Mamu allele we have analyzed the accuracy of four predictive algorithms

More information

2/10/2016. Evaluation of MIA FORA NGS HLA test and software. Disclosure. NGS-HLA typing requirements for the Stanford Blood Center

2/10/2016. Evaluation of MIA FORA NGS HLA test and software. Disclosure. NGS-HLA typing requirements for the Stanford Blood Center Evaluation of MIA FORA NGS HLA test and software Lisa Creary, PhD Department of Pathology Stanford Blood Center Research & Development Group Disclosure Alpha and Beta Studies Sirona Genomics Reagents,

More information

Structure and Function of Antigen Recognition Molecules

Structure and Function of Antigen Recognition Molecules MICR2209 Structure and Function of Antigen Recognition Molecules Dr Allison Imrie allison.imrie@uwa.edu.au 1 Synopsis: In this lecture we will examine the major receptors used by cells of the innate and

More information

Supplementary Table 1. Functional avidities of survivin-specific T-cell clones against LML-peptide

Supplementary Table 1. Functional avidities of survivin-specific T-cell clones against LML-peptide Supplementary Table 1. Functional avidities of survivin-specific T-cell clones against LML-peptide pulsed T2 cells. clone avidity by 4-hour 51 Cr-release assay 50% lysis at E:T 10:1 [LML peptide, M] #24

More information

The Major Histocompatibility Complex (MHC)

The Major Histocompatibility Complex (MHC) The Major Histocompatibility Complex (MHC) An introduction to adaptive immune system before we discuss MHC B cells The main cells of adaptive immune system are: -B cells -T cells B cells: Recognize antigens

More information

Page 4: Antigens: Self-Antigens The body has a vast number of its own antigens called self-antigens. These normally do not trigger immune responses.

Page 4: Antigens: Self-Antigens The body has a vast number of its own antigens called self-antigens. These normally do not trigger immune responses. Common Characteristics of B and T Lymphocytes Graphics are used with permission of Pearson Education Inc., publishing as Benjamin Cummings (http://www.aw-bc.com). Page 1: Introduction While B and T lymphocytes

More information

Supplementary Data 1. Alanine substitutions and position variants of APNCYGNIPL. Applied in

Supplementary Data 1. Alanine substitutions and position variants of APNCYGNIPL. Applied in Supplementary Data 1. Alanine substitutions and position variants of APNCYGNIPL. Applied in Supplementary Fig. 2 Substitution Sequence Position variant Sequence original APNCYGNIPL original APNCYGNIPL

More information

The Adaptive Immune Response. T-cells

The Adaptive Immune Response. T-cells The Adaptive Immune Response T-cells T Lymphocytes T lymphocytes develop from precursors in the thymus. Mature T cells are found in the blood, where they constitute 60% to 70% of lymphocytes, and in T-cell

More information

Variant Classification. Author: Mike Thiesen, Golden Helix, Inc.

Variant Classification. Author: Mike Thiesen, Golden Helix, Inc. Variant Classification Author: Mike Thiesen, Golden Helix, Inc. Overview Sequencing pipelines are able to identify rare variants not found in catalogs such as dbsnp. As a result, variants in these datasets

More information

CD44

CD44 MR1-5-OP-RU CD24 CD24 CD44 MAIT cells 2.78 11.2 WT RORγt- GFP reporter 1 5 1 4 1 3 2.28 1 5 1 4 1 3 4.8 1.6 8.1 1 5 1 4 1 3 1 5 1 4 1 3 3.7 3.21 8.5 61.7 1 2 1 3 1 4 1 5 TCRβ 2 1 1 3 1 4 1 5 CD44 1 2 GFP

More information

Supplementary Fig. 1: Ex vivo tetramer enrichment with anti-c-myc beads

Supplementary Fig. 1: Ex vivo tetramer enrichment with anti-c-myc beads Supplementary Fig. 1: Ex vivo tetramer enrichment with anti-c-myc beads Representative example of comparative ex vivo tetramer enrichment performed in three independent experiments with either conventional

More information

Tissue distribution and clonal diversity of the T and B cell repertoire in type 1 diabetes

Tissue distribution and clonal diversity of the T and B cell repertoire in type 1 diabetes Tissue distribution and clonal diversity of the T and B cell repertoire in type 1 diabetes Howard R. Seay, 1 Erik Yusko, 2 Stephanie J. Rothweiler, 1 Lin Zhang, 1 Amanda L. Posgai, 1 Martha Campbell-Thompson,

More information

The Major Histocompatibility Complex of Genes

The Major Histocompatibility Complex of Genes The Major Histocompatibility Complex of Genes Topic 4 The Major Histocompatibility Complex Outline of Lectures The immunological reasons for transplant rejection How the MHC was discovered using inbred

More information

Introduction. and Department of Medical Oncology, Dana-Farber Cancer Institute, 77 Avenue Louis Pasteur, Boston, MA 02115, USA

Introduction. and Department of Medical Oncology, Dana-Farber Cancer Institute, 77 Avenue Louis Pasteur, Boston, MA 02115, USA doi:10.1016/j.jmb.2007.06.057 J. Mol. Biol. (2007) 372, 535 548 CTL Recognition of a Protective Immunodominant Influenza A Virus Nucleoprotein Epitope Utilizes a Highly Restricted Vβ but Diverse Vα Repertoire:

More information

Nature Genetics: doi: /ng Supplementary Figure 1. Workflow of CDR3 sequence assembly from RNA-seq data.

Nature Genetics: doi: /ng Supplementary Figure 1. Workflow of CDR3 sequence assembly from RNA-seq data. Supplementary Figure 1 Workflow of CDR3 sequence assembly from RNA-seq data. Paired-end short-read RNA-seq data were mapped to human reference genome hg19, and unmapped reads in the TCR regions were extracted

More information

Profiling HLA motifs by large scale peptide sequencing Agilent Innovators Tour David K. Crockett ARUP Laboratories February 10, 2009

Profiling HLA motifs by large scale peptide sequencing Agilent Innovators Tour David K. Crockett ARUP Laboratories February 10, 2009 Profiling HLA motifs by large scale peptide sequencing 2009 Agilent Innovators Tour David K. Crockett ARUP Laboratories February 10, 2009 HLA Background The human leukocyte antigen system (HLA) is the

More information

TITLE: Development of Antigen Presenting Cells for adoptive immunotherapy in prostate cancer

TITLE: Development of Antigen Presenting Cells for adoptive immunotherapy in prostate cancer AD Award Number: W8-XWH-5-- TITLE: Development of Antigen Presenting Cells for adoptive immunotherapy in prostate cancer PRINCIPAL INVESTIGATOR: Mathias Oelke, Ph.D. CONTRACTING ORGANIZATION: Johns Hopkins

More information

COURSE: Medical Microbiology, MBIM 650/720 - Fall TOPIC: Antigen Processing, MHC Restriction, & Role of Thymus Lecture 12

COURSE: Medical Microbiology, MBIM 650/720 - Fall TOPIC: Antigen Processing, MHC Restriction, & Role of Thymus Lecture 12 COURSE: Medical Microbiology, MBIM 650/720 - Fall 2008 TOPIC: Antigen Processing, MHC Restriction, & Role of Thymus Lecture 12 FACULTY: Dr. Mayer Office: Bldg. #1, Rm B32 Phone: 733-3281 Email: MAYER@MED.SC.EDU

More information

1,000 in silico simulated alpha, beta, gamma and delta TCR repertoires were created.

1,000 in silico simulated alpha, beta, gamma and delta TCR repertoires were created. 938 939 940 941 942 Figure S1 Schematic of the in silico TCRminer and MiXCR validation. 1,000 in silico simulated alpha, beta, gamma and delta TCR repertoires were created. Then, 100,000 simulated 80 bp

More information

MHC class I MHC class II Structure of MHC antigens:

MHC class I MHC class II Structure of MHC antigens: MHC class I MHC class II Structure of MHC antigens: MHC class I antigens consist of a transmembrane heavy chain (α chain) that is non-covalently associated with β2- microglobulin. Membrane proximal domain

More information

Genetics and Genomics in Medicine Chapter 8 Questions

Genetics and Genomics in Medicine Chapter 8 Questions Genetics and Genomics in Medicine Chapter 8 Questions Linkage Analysis Question Question 8.1 Affected members of the pedigree above have an autosomal dominant disorder, and cytogenetic analyses using conventional

More information

Cover Page. The handle holds various files of this Leiden University dissertation.

Cover Page. The handle   holds various files of this Leiden University dissertation. Cover Page The handle http://hdl.handle.net/1887/20898 holds various files of this Leiden University dissertation. Author: Jöris, Monique Maria Title: Challenges in unrelated hematopoietic stem cell transplantation.

More information

Introduction to LOH and Allele Specific Copy Number User Forum

Introduction to LOH and Allele Specific Copy Number User Forum Introduction to LOH and Allele Specific Copy Number User Forum Jonathan Gerstenhaber Introduction to LOH and ASCN User Forum Contents 1. Loss of heterozygosity Analysis procedure Types of baselines 2.

More information

Low Avidity CMV + T Cells accumulate in Old Humans

Low Avidity CMV + T Cells accumulate in Old Humans Supplementary Figure Legends Supplementary Figure 1. CD45RA expressing CMVpp65-specific T cell populations accumulate within HLA-A*0201 and HLA-B*0701 individuals Pooled data showing the size of the NLV/HLA-A*0201-specific

More information

Nature Methods: doi: /nmeth.3115

Nature Methods: doi: /nmeth.3115 Supplementary Figure 1 Analysis of DNA methylation in a cancer cohort based on Infinium 450K data. RnBeads was used to rediscover a clinically distinct subgroup of glioblastoma patients characterized by

More information

Supplementary Appendix

Supplementary Appendix Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Johnson DB, Balko JM, Compton ML, et al. Fulminant myocarditis

More information

How T cells recognize antigen: The T Cell Receptor (TCR) Identifying the TCR: Why was it so hard to do? Monoclonal antibody approach

How T cells recognize antigen: The T Cell Receptor (TCR) Identifying the TCR: Why was it so hard to do? Monoclonal antibody approach How T cells recognize antigen: The T Cell Receptor (TCR) Identifying the TCR: Why was it so hard to do By the early 1980s, much about T cell function was known, but the receptor genes had not been identified

More information

A second type of TCR TCR: An αβ heterodimer

A second type of TCR TCR: An αβ heterodimer How s recognize antigen: The T Cell Receptor (TCR) Identifying the TCR: Why was it so hard to do By the early 1980s, much about function was known, but the receptor genes had not been identified Recall

More information

T cell Receptor. Chapter 9. Comparison of TCR αβ T cells

T cell Receptor. Chapter 9. Comparison of TCR αβ T cells Chapter 9 The αβ TCR is similar in size and structure to an antibody Fab fragment T cell Receptor Kuby Figure 9-3 The αβ T cell receptor - Two chains - α and β - Two domains per chain - constant (C) domain

More information

TITLE: Development of Antigen Presenting Cells for adoptive immunotherapy in prostate cancer

TITLE: Development of Antigen Presenting Cells for adoptive immunotherapy in prostate cancer AD Award Number: W8XWH-5-- TITLE: Development of Antigen Presenting Cells for adoptive immunotherapy in prostate cancer PRINCIPAL INVESTIGATOR: Mathias Oelke Ph.D. CONTRACTING ORGANIZATION: Johns Hopkins

More information

Test Bank for Basic Immunology Functions and Disorders of the Immune System 4th Edition by Abbas

Test Bank for Basic Immunology Functions and Disorders of the Immune System 4th Edition by Abbas Test Bank for Basic Immunology Functions and Disorders of the Immune System 4th Edition by Abbas Chapter 04: Antigen Recognition in the Adaptive Immune System Test Bank MULTIPLE CHOICE 1. Most T lymphocytes

More information

Introduction. Introduction. Lymphocyte development (maturation)

Introduction. Introduction. Lymphocyte development (maturation) Introduction Abbas Chapter 8: Lymphocyte Development and the Rearrangement and Expression of Antigen Receptor Genes Christina Ciaccio, MD Children s Mercy Hospital January 5, 2009 Lymphocyte development

More information

CELL BIOLOGY - CLUTCH CH THE IMMUNE SYSTEM.

CELL BIOLOGY - CLUTCH CH THE IMMUNE SYSTEM. !! www.clutchprep.com CONCEPT: OVERVIEW OF HOST DEFENSES The human body contains three lines of against infectious agents (pathogens) 1. Mechanical and chemical boundaries (part of the innate immune system)

More information

Contents. Just Classifier? Rules. Rules: example. Classification Rule Generation for Bioinformatics. Rule Extraction from a trained network

Contents. Just Classifier? Rules. Rules: example. Classification Rule Generation for Bioinformatics. Rule Extraction from a trained network Contents Classification Rule Generation for Bioinformatics Hyeoncheol Kim Rule Extraction from Neural Networks Algorithm Ex] Promoter Domain Hybrid Model of Knowledge and Learning Knowledge refinement

More information

The T cell receptor for MHC-associated peptide antigens

The T cell receptor for MHC-associated peptide antigens 1 The T cell receptor for MHC-associated peptide antigens T lymphocytes have a dual specificity: they recognize polymporphic residues of self MHC molecules, and they also recognize residues of peptide

More information

Adaptive Immune Response Day 2. The Adaptive Immune Response

Adaptive Immune Response Day 2. The Adaptive Immune Response Adaptive Immune Response Day 2 Chapter 16 The Adaptive Immune Response 1 The B cell receptor vs. the T cell receptor. The B cell receptor vs. the T cell receptor. 2 Which T cells have CD4 and which have

More information

Significance of the MHC

Significance of the MHC CHAPTER 8 Major Histocompatibility Complex (MHC) What is is MHC? HLA H-2 Minor histocompatibility antigens Peter Gorer & George Sneell (1940) Significance of the MHC role in immune response role in organ

More information

CS229 Final Project Report. Predicting Epitopes for MHC Molecules

CS229 Final Project Report. Predicting Epitopes for MHC Molecules CS229 Final Project Report Predicting Epitopes for MHC Molecules Xueheng Zhao, Shanshan Tuo Biomedical informatics program Stanford University Abstract Major Histocompatibility Complex (MHC) plays a key

More information

MHC Tetramers and Monomers for Immuno-Oncology and Autoimmunity Drug Discovery

MHC Tetramers and Monomers for Immuno-Oncology and Autoimmunity Drug Discovery MHC Tetramers and Monomers for Immuno-Oncology and Autoimmunity Drug Discovery Your Partner in Drug Discovery and Research MHC Tetramer Background T-Cell Receptors recognize and bind to complexes composed

More information

Supplemental Information. Antigen Identification. for Orphan T Cell Receptors Expressed. on Tumor-Infiltrating Lymphocytes

Supplemental Information. Antigen Identification. for Orphan T Cell Receptors Expressed. on Tumor-Infiltrating Lymphocytes Cell, Volume 7 Supplemental nformation Antigen dentification for Orphan T Cell Receptors Expressed on Tumor-nfiltrating ymphocytes Marvin H. Gee, Arnold Han, Shane M. ofgren, John F. Beausang, Juan. Mendoza,

More information

Chapter 1. Introduction

Chapter 1. Introduction Chapter 1 Introduction 1.1 Motivation and Goals The increasing availability and decreasing cost of high-throughput (HT) technologies coupled with the availability of computational tools and data form a

More information

Adaptive Immune System

Adaptive Immune System Short Course on Immunology Adaptive Immune System Bhargavi Duvvuri Ph.D IIIrd Year (Immunology) bhargavi@yorku.ca Supervisor Dr.Gillian E Wu Professor, School of Kinesiology and Health Sciences York University,

More information

AVENIO ctdna Analysis Kits The complete NGS liquid biopsy solution EMPOWER YOUR LAB

AVENIO ctdna Analysis Kits The complete NGS liquid biopsy solution EMPOWER YOUR LAB Analysis Kits The complete NGS liquid biopsy solution EMPOWER YOUR LAB Analysis Kits Next-generation performance in liquid biopsies 2 Accelerating clinical research From liquid biopsy to next-generation

More information

B F. Location of MHC class I pockets termed B and F that bind P2 and P9 amino acid side chains of the peptide

B F. Location of MHC class I pockets termed B and F that bind P2 and P9 amino acid side chains of the peptide Different MHC alleles confer different functional properties on the adaptive immune system by specifying molecules that have different peptide binding abilities Location of MHC class I pockets termed B

More information

Autoimmunity to hypocretin and molecular mimicry to flu in type 1 narcolepsy

Autoimmunity to hypocretin and molecular mimicry to flu in type 1 narcolepsy Autoimmunity to hypocretin and molecular mimicry to flu in type 1 narcolepsy Guo Luo a, Aditya Ambati a,1, Ling Lin a,1, Mélodie Bonvalet a, Markku Partinen b,c, Xuhuai Ji d, Holden erry Maecker d, and

More information

TITLE: Development of Antigen Presenting Cells for adoptive immunotherapy in prostate cancer

TITLE: Development of Antigen Presenting Cells for adoptive immunotherapy in prostate cancer AD Award Number: W8-XWH-5-- TITLE: Development of Antigen Presenting Cells for adoptive immunotherapy in prostate cancer PRINCIPAL INVESTIGATOR: Mathias Oelke,. CONTRACTING ORGANIZATION: Johns Hopkins

More information

Degenerate T-cell Recognition of Peptides on MHC Molecules Creates Large Holes in the T-cell Repertoire

Degenerate T-cell Recognition of Peptides on MHC Molecules Creates Large Holes in the T-cell Repertoire Degenerate T-cell Recognition of Peptides on MHC Molecules Creates Large Holes in the T-cell Repertoire Jorg J. A. Calis*, Rob J. de Boer, Can Keşmir Theoretical Biology & Bioinformatics, Utrecht University,

More information

Nature Genetics: doi: /ng Supplementary Figure 1. Rates of different mutation types in CRC.

Nature Genetics: doi: /ng Supplementary Figure 1. Rates of different mutation types in CRC. Supplementary Figure 1 Rates of different mutation types in CRC. (a) Stratification by mutation type indicates that C>T mutations occur at a significantly greater rate than other types. (b) As for the

More information

Basic Immunology. Lecture 5 th and 6 th Recognition by MHC. Antigen presentation and MHC restriction

Basic Immunology. Lecture 5 th and 6 th Recognition by MHC. Antigen presentation and MHC restriction Basic Immunology Lecture 5 th and 6 th Recognition by MHC. Antigen presentation and MHC restriction Molecular structure of MHC, subclasses, genetics, functions. Antigen presentation and MHC restriction.

More information

Abstract. Optimization strategy of Copy Number Variant calling using Multiplicom solutions APPLICATION NOTE. Introduction

Abstract. Optimization strategy of Copy Number Variant calling using Multiplicom solutions APPLICATION NOTE. Introduction Optimization strategy of Copy Number Variant calling using Multiplicom solutions Michael Vyverman, PhD; Laura Standaert, PhD and Wouter Bossuyt, PhD Abstract Copy number variations (CNVs) represent a significant

More information

Significance of the MHC

Significance of the MHC CHAPTER 8 Major Histocompatibility Complex (MHC) What is MHC? HLA H-2 Minor histocompatibility antigens Peter Gorer & George Sneell (1940) - MHC molecules were initially discovered during studies aimed

More information

AG MHC HLA APC Ii EPR TAP ABC CLIP TCR

AG MHC HLA APC Ii EPR TAP ABC CLIP TCR !! AG MHC HLA APC Ii EPR TAP ABC CLIP TCR Antigen Major Histocompartibility Complex Human Leukocyte Antigen Antigen Presenting Cell Invariant Chain Endoplasmatic Reticulum Transporters Associated with

More information

Bjoern Peters La Jolla Institute for Allergy and Immunology Buenos Aires, Oct 31, 2012

Bjoern Peters La Jolla Institute for Allergy and Immunology Buenos Aires, Oct 31, 2012 www.iedb.org Bjoern Peters bpeters@liai.org La Jolla Institute for Allergy and Immunology Buenos Aires, Oct 31, 2012 Overview 1. Introduction to the IEDB 2. Application: 2009 Swine-origin influenza virus

More information

DIRECT IDENTIFICATION OF NEO-EPITOPES IN TUMOR TISSUE

DIRECT IDENTIFICATION OF NEO-EPITOPES IN TUMOR TISSUE DIRECT IDENTIFICATION OF NEO-EPITOPES IN TUMOR TISSUE Eustache Paramithiotis PhD Vice President, Biomarker Discovery & Diagnostics 17 March 2016 PEPTIDE PRESENTATION BY MHC MHC I Antigen presentation by

More information

Detection of aneuploidy in a single cell using the Ion ReproSeq PGS View Kit

Detection of aneuploidy in a single cell using the Ion ReproSeq PGS View Kit APPLICATION NOTE Ion PGM System Detection of aneuploidy in a single cell using the Ion ReproSeq PGS View Kit Key findings The Ion PGM System, in concert with the Ion ReproSeq PGS View Kit and Ion Reporter

More information

all of the above the ability to impart long term memory adaptive immunity all of the above bone marrow none of the above

all of the above the ability to impart long term memory adaptive immunity all of the above bone marrow none of the above 1. (3 points) Immediately after a pathogen enters the body, it faces the cells and soluble proteins of the innate immune system. Which of the following are characteristics of innate immunity? a. inflammation

More information

Supplementary Figure 1. Example of gating strategy

Supplementary Figure 1. Example of gating strategy Supplementary Figure 1. Example of gating strategy Legend Supplementary Figure 1: First, gating is performed to include only single cells (singlets) (A) and CD3+ cells (B). After gating on the lymphocyte

More information

Supplementary Table 1. T-cell receptor sequences of HERV-K(HML-2)-specific CD8 + T cell clone.

Supplementary Table 1. T-cell receptor sequences of HERV-K(HML-2)-specific CD8 + T cell clone. Supplementary Table 1. T-cell receptor sequences of HERV-K(HML-2)-specific CD8 + T cell clone. alpha beta ATGCTCCTGCTGCTCGTCCCAGTGCTCGAGGTGATTTTTACTCTGGGAGGAACCAGAGCC CAGTCGGTGACCCAGCTTGACAGCCACGTCTCTGTCTCTGAAGGAACCCCGGTGCTGCTG

More information

Surface plasmon resonance (SPR) analysis

Surface plasmon resonance (SPR) analysis Surface plasmon resonance (SPR) analysis Soluble CD8αα and was manufactured as described previously. 1,2 The C12C heterodimeric TCR was produced using an engineered disulfide bridge between the constant

More information

HD1 (FLU) HD2 (EBV) HD2 (FLU)

HD1 (FLU) HD2 (EBV) HD2 (FLU) ramer staining + anti-pe beads ramer staining a HD1 (FLU) HD2 (EBV) HD2 (FLU).73.11.56.46.24 1.12 b CD127 + c CD127 + d CD127 - e CD127 - PD1 - PD1 + PD1 + PD1-1 1 1 1 %CD127 + PD1-8 6 4 2 + anti-pe %CD127

More information

EBV Infection and Immunity. Andrew Hislop Institute for Cancer Studies University of Birmingham

EBV Infection and Immunity. Andrew Hislop Institute for Cancer Studies University of Birmingham EBV Infection and Immunity Andrew Hislop Institute for Cancer Studies University of Birmingham EBV Introduction Large ds DNA virus Spread by saliva contact Lifelong infection Predominantly B-lymphotropic

More information

Antigen Presentation and T Lymphocyte Activation. Shiv Pillai MD, PhD Massachusetts General Hospital Harvard Medical School. FOCiS

Antigen Presentation and T Lymphocyte Activation. Shiv Pillai MD, PhD Massachusetts General Hospital Harvard Medical School. FOCiS 1 Antigen Presentation and T Lymphocyte Activation Shiv Pillai MD, PhD Massachusetts General Hospital Harvard Medical School FOCiS 2 Lecture outline Overview of T cell activation and the rules of adaptive

More information

Mutation Detection and CNV Analysis for Illumina Sequencing data from HaloPlex Target Enrichment Panels using NextGENe Software for Clinical Research

Mutation Detection and CNV Analysis for Illumina Sequencing data from HaloPlex Target Enrichment Panels using NextGENe Software for Clinical Research Mutation Detection and CNV Analysis for Illumina Sequencing data from HaloPlex Target Enrichment Panels using NextGENe Software for Clinical Research Application Note Authors John McGuigan, Megan Manion,

More information

Generation of antibody diversity October 18, Ram Savan

Generation of antibody diversity October 18, Ram Savan Generation of antibody diversity October 18, 2016 Ram Savan savanram@uw.edu 441 Lecture #10 Slide 1 of 30 Three lectures on antigen receptors Part 1 : Structural features of the BCR and TCR Janeway Chapter

More information

Validation of the MIA FORA NGS FLEX Assay Using Buccal Swabs as the Sample Source

Validation of the MIA FORA NGS FLEX Assay Using Buccal Swabs as the Sample Source S. Krishnakumar, M. Li, C. Wang, M, Osada, R. Kuehn, M. Fukushima and Y. Thorstenson Immucor, Inc. S. Krishnakumar, M. Li, C. Wang, M, Osada, R. Kuehn, M. Fukushima and Y. Thorstenson Immucor, Inc. Introduction

More information

Key Concept B F. How do peptides get loaded onto the proper kind of MHC molecule?

Key Concept B F. How do peptides get loaded onto the proper kind of MHC molecule? Location of MHC class I pockets termed B and F that bind P and P9 amino acid side chains of the peptide Different MHC alleles confer different functional properties on the adaptive immune system by specifying

More information

Lentiviral Delivery of Combinatorial mirna Expression Constructs Provides Efficient Target Gene Repression.

Lentiviral Delivery of Combinatorial mirna Expression Constructs Provides Efficient Target Gene Repression. Supplementary Figure 1 Lentiviral Delivery of Combinatorial mirna Expression Constructs Provides Efficient Target Gene Repression. a, Design for lentiviral combinatorial mirna expression and sensor constructs.

More information

SMPD 287 Spring 2015 Bioinformatics in Medical Product Development. Final Examination

SMPD 287 Spring 2015 Bioinformatics in Medical Product Development. Final Examination Final Examination You have a choice between A, B, or C. Please email your solutions, as a pdf attachment, by May 13, 2015. In the subject of the email, please use the following format: firstname_lastname_x

More information

AVENIO family of NGS oncology assays ctdna and Tumor Tissue Analysis Kits

AVENIO family of NGS oncology assays ctdna and Tumor Tissue Analysis Kits AVENIO family of NGS oncology assays ctdna and Tumor Tissue Analysis Kits Accelerating clinical research Next-generation sequencing (NGS) has the ability to interrogate many different genes and detect

More information

OPTN/UNOS Policy Notice Review of HLA Tables (2016)

OPTN/UNOS Policy Notice Review of HLA Tables (2016) Review of HLA Tables (2016) Sponsoring Committee: Policy/Bylaws Affected: Histocompatibility Policy 4.10 (Reference Tables of HLA Antigen Values and Split Equivalences) Public Comment: July 31, 2017 October

More information

SUPPLEMENTARY APPENDIX

SUPPLEMENTARY APPENDIX SUPPLEMENTARY APPENDIX 1) Supplemental Figure 1. Histopathologic Characteristics of the Tumors in the Discovery Cohort 2) Supplemental Figure 2. Incorporation of Normal Epidermal Melanocytic Signature

More information

Below, we included the point-to-point response to the comments of both reviewers.

Below, we included the point-to-point response to the comments of both reviewers. To the Editor and Reviewers: We would like to thank the editor and reviewers for careful reading, and constructive suggestions for our manuscript. According to comments from both reviewers, we have comprehensively

More information